Jianyong Zhong Selected Research

Jianyong Zhong Research Topics

Disease

5	Chronic Renal Insufficiency 01/2023 - 01/2018
5	Kidney Diseases (Kidney Disease) 11/2022 - 01/2018
5	Fibrosis (Cirrhosis) 11/2022 - 06/2014
4	Proteinuria 05/2022 - 01/2016
3	Albuminuria 12/2023 - 11/2022
2	Inflammation (Inflammations) 01/2021 - 01/2019
2	Hypoxia (Hypoxemia) 01/2021 - 12/2017
2	Atherosclerosis 01/2019 - 01/2019
1	Hyperglycemia 12/2023
1	Diabetic Nephropathies (Diabetic Nephropathy) 12/2023
1	Anemia 01/2023
1	Dysbiosis 01/2023
1	Sclerosis 05/2022
1	Edema (Dropsy) 12/2020
1	Ureteral Obstruction 12/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2019
1	Body Weight (Weight, Body) 01/2016
1	Hypertension (High Blood Pressure) 01/2016
1	Lung Injury 01/2010
1	Sepsis (Septicemia) 01/2010
1	Endotoxemia 01/2010

Drug/Important Bio-Agent (IBA)

3	AldosteroneIBA 05/2022 - 01/2018
2	isolevuglandinIBA 11/2022 - 01/2021
2	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2021 - 11/2019
2	CollagenIBA 01/2021 - 12/2019
2	Plasminogen Activators (Plasminogen Activator)IBA 12/2019 - 06/2014
2	Plasminogen Activator Inhibitor 1IBA 12/2019 - 06/2014
2	CholesterolIBA 10/2019 - 01/2018
2	Indicators and Reagents (Reagents)IBA 12/2018 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 01/2017 - 01/2016
1	Dipeptidyl-Peptidase IV InhibitorsIBA 12/2023
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2023
1	Uremic ToxinsIBA 01/2023
1	CreatinineIBA 01/2023
1	Erythropoietin FDA Link 01/2023
1	Losartan (Cozaar)FDA LinkGeneric 05/2022
1	Antihypertensive Agents (Antihypertensives)IBA 05/2022
1	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 11/2021
1	pimonidazoleIBA 01/2021
1	oxalylglycineIBA 01/2021
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2021
1	Furosemide (Lasix)FDA LinkGeneric 12/2020
1	TenascinIBA 12/2019
1	Green Fluorescent ProteinsIBA 12/2019
1	Protein Isoforms (Isoforms)IBA 11/2019
1	HDL LipoproteinsIBA 10/2019
1	Apolipoproteins E (ApoE)IBA 01/2019
1	Immunotoxins (Immunotoxin)IBA 01/2019
1	Protein Kinases (Protein Kinase)IBA 01/2019
1	MicroRNAs (MicroRNA)IBA 01/2019
1	Cytochrome P-450 CYP11B2 (CYP11B2)IBA 12/2018
1	Lipoproteins (Lipoprotein)IBA 01/2018
1	Liver X ReceptorsIBA 01/2018
1	LipidsIBA 01/2018
1	oxidized low density lipoproteinIBA 01/2018
1	Diphtheria ToxinIBA 12/2017
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 12/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2017
1	GelatinasesIBA 01/2017
1	apolipoprotein A-IV (apolipoprotein AIV)IBA 01/2017
1	Messenger RNA (mRNA)IBA 06/2014
1	SaltsIBA 06/2014
1	Fibrinolysin FDA Link 06/2014
1	VitronectinIBA 06/2014
1	Angiotensin IIIBA 06/2014
1	PeriostinIBA 06/2014
1	Peptide Hydrolases (Proteases)FDA Link 06/2014
1	salicylhydroxamic acid (SHAM)IBA 01/2010
1	Hemostatics (Antihemorrhagics)IBA 01/2010
1	Endothelin-1 (Endothelin 1)IBA 01/2010
1	von Willebrand FactorIBA 01/2010

Therapy/Procedure

4	Therapeutics 05/2022 - 01/2010
1	Bioreactors (Bioreactor) 01/2010